S-1 plus cisplatin: Clinical Trials

8 trials of S-1 plus cisplatin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown. 4 Phase 3, 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Unknown 1
Phase 12Completed 2
Phase 22Completed 1, Unknown 1

Follow S-1 plus cisplatin: new trials by email Literature Review of S-1 plus cisplatin trials Research Report on S-1 plus cisplatin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer
TAS-118 plus Oxaliplatin, S-1 plus Cisplatin - Gastric Cancer
Phase 3CompletedTaiho Pharmaceutical Co., Ltd.7112014-12-012021-12-20
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Capecitabine/cisplatin, S-1/cisplatin, Capecitabine/oxaliplatin - Gastric Cancer
Phase 3CompletedSeoul National University Hospital1112014-02-012020-10-23
S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer
S-1, S-1 plus cisplatin - Gastric Cancer
Phase 2UnknownKyungpook National University Hospital2182011-09-012012-01-05
Trial of S-1 Plus Cisplatin in Gastric Cancer
s-1 plus cisplatin, 5-Fu plus cisplatin - Gastric Cancer
Phase 3UnknownSun Yat-sen University2702008-09-012011-07-25
Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma
S-1 plus cisplatin, Gemcitabine plus Cisplatin - Metastatic Biliary Cancer
Phase 2CompletedAsan Medical Center922008-03-012011-12-06
Evaluating Patients With Impaired Hepatic Function
S-1/Cisplatin - Impaired Hepatic Function
Phase 1CompletedTaiho Oncology, Inc.242006-02-012024-09-03
Evaluating Patients With Varying Degrees of Renal Function
S-1/Cisplatin - Renal Impairment
Phase 1CompletedTaiho Oncology, Inc.242006-02-012024-09-05
A Safety and Efficacy Study in Patients With Gastric Cancer
S-1/Cisplatin, 5-FU/cisplatin - Gastric Cancer
Phase 3CompletedTaiho Oncology, Inc.10532005-05-012024-09-19

Conditions studied

Stomach Neoplasms (5)  ·  Biliary Tract Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Renal Insufficiency (1)

Sponsors

Taiho Oncology, Inc. (3)  ·  Asan Medical Center (1)  ·  Kyungpook National University Hospital (1)  ·  Seoul National University Hospital (1)  ·  Sun Yat-sen University (1)  ·  Taiho Pharmaceutical Co., Ltd. (1)

Countries

South Korea (4)  ·  United States (3)  ·  Canada (1)  ·  China (1)  ·  Japan (1)

Top investigators

Fabio Benedetti, MD (1)  ·  MJ Kang, MD, MSc (1)  ·  Wansik Yu, Professor (1)

Results publications

PMID 22559158, PMID 23899532, PMID 25707610, PMID 26439700, PMID 32682457